{
"revenue_history": [
NaN,
0.61,
3.78,
0.64,
1.4
],
"net_profit_history": [
NaN,
-2.89,
-1.33,
-3.77,
-0.8
],
"financial_years": [
"2021",
"2022",
"2023",
"2024",
"2025"
],
"roe": "-8.2%",
"net_margin": "-55.4%"
}
{
"pe": null,
"pb": "2.405241",
"pe_quantile": null,
"pb_quantile": null,
"industry_pe": null,
"dcf": null,
"pe_history": null,
"dcf_simple": null,
"dcf_sensitivity": null
}
{
"intangible": null,
"switching": null,
"network": null,
"scale": null,
"scores": {
"intangible": 5,
"switching": 5,
"network": 5,
"scale": 5
},
"rd_summary": null,
"web_search_snippets": {
"intangible": [],
"switching": [],
"network": [],
"scale": [],
"rd": []
},
"moat_framework": [
"intangible",
"switching",
"network",
"scale",
"efficient_scale"
]
}
{
"kline_count": 501,
"indicators": {
"last_close": 25.700000762939453,
"ma5": 25.194000244140625,
"ma10": 24.8060001373291,
"ma20": 24.63050022125244,
"ma60": 26.473750114440918,
"ma120": 28.89483338991801,
"ma200": 28.440475034713746,
"above_ma20": true,
"above_ma200": false,
"ma_bull_alignment": false,
"macd_dif": -0.4483479041508893,
"macd_dea": -0.6718662170765883,
"macd_hist": 0.44703662585139803,
"macd_golden_cross": false,
"rsi_14": 53.225809609175414,
"kdj_k": 49.1,
"kdj_d": 47.8,
"kdj_j": 51.9,
"obv": -7130400.0,
"obv_trend_up": false,
"williams_r": -32.8,
"year_high": 37.91999816894531,
"year_low": 20.600000381469727,
"pct_from_year_high": -32.2257331120165,
"stage": 1,
"vol_5_vs_20": 1.1547031830280174,
"vcp_score": 0.25462833860433587
},
"stage": "Stage 1 底部",
"ma_align": "非多头",
"macd": "水下",
"rsi": "53",
"chip_distribution": null,
"candles_60d": [
{
"date": "2026-07-17",
"open": 27.37,
"close": 27.53,
"high": 28.51,
"low": 27.1
},
{
"date": "2026-07-20",
"open": 27.75,
"close": 26.33,
"high": 28.13,
"low": 26.19
},
{
"date": "2026-07-21",
"open": 26.5,
"close": 27.29,
"high": 27.77,
"low": 26.1
},
{
"date": "2026-07-22",
"open": 26.92,
"close": 26.64,
"high": 27.17,
"low": 26.47
},
{
... (truncated)
{
"_note": "capital_flow only A-share / HK for now"
}
{
"_note": "lhb only A-share"
}
{
"industry": "Biotechnology",
"self": {
"code": "BEAM",
"name": "Beam Therapeutics Inc.",
"industry": "Biotechnology",
"market_cap": 2654492928,
"price": 25.7,
"change_pct": 4.47155,
"pe_ttm": null,
"pb": 2.405241
},
"peer_table": null,
"peer_comparison": null,
"rank": null,
"peers_top20_raw": null,
"fallback_reason": null
}
{
"main_business_breakdown": null,
"main_business_raw": null,
"ths_zyjs": null,
"products": null,
"upstream": null,
"downstream": null,
"client_concentration": null,
"supplier_concentration": null,
"_note": "上下游基于主营/产品/经营范围推断,精确数据需年报附注"
}
{
"industry": "Biotechnology",
"growth": null,
"tam": null,
"penetration": null,
"lifecycle": null,
"note": null,
"cninfo_metrics": null,
"total_companies": null,
"industry_pe_weighted": null,
"dynamic_snippets": {
"景气度": [],
"TAM": [],
"周期": []
},
"needs_web_search": false,
"web_search_queries": null,
"_autofill_failed": {
"query": "Biotechnology 2026 行业增速 TAM 市场规模 渗透率",
"reason": "MX/ddgs 都没有返回内容"
}
}
{
"core_material": null,
"price_trend": null,
"price_history_12m": null,
"materials_detail": null,
"cost_share": null,
"import_dep": null,
"industry_resolved": "BEAM",
"_autofill_failed": {
"query": "Beam Therapeutics Inc. BEAM 主营业务 主要原材料 成本构成",
"reason": "MX/ddgs 都没有返回内容"
}
}
{
"linked_contract": "无直接关联品种",
"contract_trend": "海大集团(002311)_公司公告_海大集团:2024年年度报告新浪财经 — Apr 22, 2025 ... 种苗、动…",
"note": "Biotechnology 行业与期货市场无强相关品种",
"_autofill": {
"query": "Biotechnology 行业 上下游 期货品种 套保 大宗",
"snippet": "海大集团(002311)_公司公告_海大集团:2024年年度报告新浪财经 — Apr 22, 2025 ... 种苗、动保业务同样作为核心业务,是所有动物集约化养殖的基础;两者均有非常强的技术属性,公司将持续投入资源和努力,占领技术和产业;中山百灵生物技术股份有限公司首次公开发行股票并在创业板上市 ... — Jun 9, 2026 ... 特别注意:敬请注意,本招股说明书中部分合计数与各加数直接相加之和. 在尾数上存在差异,均系计算中四舍五入造成。 本招股说明书所引;中山百灵生物技术股份有限公司 — Jun 14, 2026 ... 市场方面,医药制药行业与经济民生息息相关,系国家重点鼓励发",
"source": "ddgs"
}
}
{
"pledge": null,
"insider_trades_1y": null,
"qualitative_search": [
"BEAM 关联交易 违规 处罚",
"BEAM 股权激励"
]
}
{
"_autofill": {
"query": "Beam Therapeutics Inc. BEAM 最新公告 重大事件 业绩 合同",
"snippet": "Press Releases - Beam Therapeutics — CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nas;Press Releases - Beam Therapeutics — CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nas;Beam Therapeutics公布2026年第二季度财务业绩,并宣布在 ... — Beam Therapeutics(纳斯",
"source": "ddgs"
},
"event_timeline": [
"Press Releases - Beam Therapeutics — CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nas;Pr"
]
}
{
"report_count": 0
}
{
"rate_cycle": "这篇文章(URL: 网页链接)2026年6月10日发表在 *Nature Biotechnology* 上的深度行业透视... - 雪球 — 这篇文章(URL:…",
"fx_trend": "中性(人民币走势)",
"geo_risk": "中性(地缘风险)",
"commodity": "中性(大宗周期)",
"industry_macro_impact": "中性",
"web_search_snippets": {
"rate_cycle": [],
"us_rate": [],
"fx_trend": [],
"geo_risk": [
{
"title": "2026年中美贸易争端大事记(持续更新中)-国际金融与经济研究中心",
"body": "Sep 22, 2026 · 2026年5月17日: 美国白宫官网发布《事实清单:特朗普总统与中国达成历史性协议》,内容包括中美同意成立中美贸易理事会和中美投资理事会;双方原则上同意在该理事会框架下讨论对等规模的关税降低;中方将回应美国在稀土及其他关键矿产供应链短缺方面 ...",
"url": "https://cifer.pbcsf.tsinghua.edu.cn/info/1161/3631.htm"
},
{
"title": "2026不断演变的中美贸易关系及企业应对_美国最高法院_关税_中国",
"body": "Mar 30, 2026 · 2026年3月27日,中国商务部公布对美国实施的贸易壁垒展开两项调查,一项针对“阻碍绿色产品贸易”的贸易措施,另一项针对“扰乱全球生产和供应链”的措施。 调查必须在六个月内完成,但可以再延长三个月。",
"url": "https://www.sohu.com/a/1003076612_120287836"
},
{
"title": "德恒出口管制经济制裁热点与合规月报(2026年第十三期) - 德恒探索 -...",
"body": "2026-01-30 时序迈入2026年1月,全球出口管制与经济制裁政策迭代提速,中、美等主要经济体密集出台针对性规制措施,清单调整、执法落地与资讯更新多点发力,为跨境贸易、投资及企业合规经营带来新的挑战与指引。",
"url": "https://www.dehenglaw.com/CN/tansuocontent/0008/035951/8.aspx?MID=0903"
}
],
"commodity": [
{
"title": "2026年下半年宏观视角下的大宗商品走势分析:大宗商品市场的主线与节...",
"body": "Jun 30, 2026 · 对资产价格友好,市场预期进一步乐观。 宏观净需求、流动性环境等变化使得大宗商品“超级周期“的基础已不存在。 2026 年下半年,大宗商品自身的属性特征和基本面情况对商品价格影响权重加大。",
"url": "https://stock.finance.sina.com.cn/stock/go.php/vReport_Show/kind/macro/rptid/836175
... (truncated)
{
"policy_dir": null,
"subsidy": null,
"monitoring": null,
"anti_trust": null,
"snippets": {
"policy_dir": [],
"subsidy": [],
"monitoring": [],
"anti_trust": []
},
"year": 2026,
"industry": "Biotechnology",
"cfachina_titles_count": 0,
"_autofill_failed": {
"query": "Biotechnology 2026 国家政策 监管动态 补贴 税收 影响",
"reason": "MX/ddgs 都没有返回内容"
}
}
{
"xueqiu_heat": "热度 100",
"thermometer_value": 100,
"guba_volume": "4 条结果",
"big_v_mentions": null,
"positive_pct": "100.0%",
"sentiment_label": "乐观",
"platform_snippets": {
"xueqiu": [
{
"title": "Beam Therapeutics (BEAM) 股票股价_股价行情_财报_数据报告 - 雪球",
"body": "雪球为您提供Beam Therapeutics (BEAM)股票实时行情,资金流向,新闻资讯,研究报告,社区互动,交易信息,个股点评,公告,财务指标分析等与Beam Therapeutics (BEAM)股票相关的信息与服务.",
"url": "https://www.xueqiu.com/S/BEAM"
},
{
"title": "$Beam Therapeutics (BEAM)$ 这家明星公司最近一直在微涨,beam选择将...",
"body": "Jul 27, 2024 · Beam Therapeutics 成立于2018年5月,由刘如谦、张锋、J. Keith Joung三位基因编辑领域顶尖大牛共同创立。 2022年2月就在纳斯达克上市。 Beam致力于开发基于单碱基编辑技术的新型精密基因药物,愿景是为患有严重疾病的患者提供终生性治愈。",
"url": "https://xueqiu.com/3996467112/298980582"
},
{
"title": "Beam Therapeutics Inc.(股票代码:BEAM) 是一家在纳斯达克上市的 ...",
"body": "Jul 8, 2026 · Beam Therapeutics Inc.(股票代码:BEAM) 是一家在纳斯达克上市的 生物科技 公司,专注于利用其专有的碱基编辑(Base Editing) 技术,为患有严重疾病的患者开发精准基因药物。",
"url": "https://xueqiu.com/6696955225/398945136"
}
],
"guba": [
{
"title": "新华策略精选股票C股吧_新华策略精选股票C分析讨论社区-东方财富网",
"body": "新华策略精选股票C股吧,股民朋友可以在这里畅所欲言,分析讨论吧名的最新动态。东方财富股吧,专业的股票论坛社区。",
"url": "https://guba.eastmoney.com/list,of025415.html"
},
{
"title": "华商龙头优势混合股吧_华商龙头优势混合分析讨论社区-东方财富网",
"body": "华商龙头优势混合股吧,股民朋友可以在这里畅所欲言,分析讨论吧名的最新动态。东方财富股吧,专业的股票论坛社区。",
"url": "https://guba.eastmoney.com/list,of008555,1778198202.h
... (truncated)
{
"trap_level": "🟡 注意",
"trap_score": 7,
"signals_hit": "2/8",
"signals_hit_count": 2,
"signals_hit_detail": [
{
"id": 6,
"name": "老师/股神人设推广",
"evidence_kws": [
"老师",
"股神",
"跟单"
],
"severity": "high"
},
{
"id": 8,
"name": "虚假研报/伪造消息",
"evidence_kws": [
"虚假",
"谣言",
"伪造"
],
"severity": "high"
}
],
"recommendation": "发现 2 个推广信号,建议核实信息源。",
"evidence_count": 6,
"high_risk_kw": "老师/股神人设推广, 虚假研报/伪造消息",
"snippets": {
"signal_1": [],
"signal_2": [
{
"title": "主力建仓完毕即将拉升,“成交量”都会出现这样的特征!",
"body": "Mar 19, 2026 · 尤其是主力完成建仓、准备拉升之前,成交量一定会露出非常明显、非常统一的特征。 今天这篇文章,我就把主力建仓完毕、即将拉升前的成交量核心信号,完整、直白、接地气地讲给你听。",
"url": "https://www.toutiao.com/article/7618843781526880787/"
},
{
"title": "主力建仓完毕即将拉升,“成交量”都会出现这样的特征!",
"body": "Apr 6, 2026 · 主力建仓完毕即将拉升,“成交量”都会出现这样的特征!, 视频播放量 852、弹幕量 5、点赞数 22、投硬币枚数 3、收藏人数 31、转发人数 4, 视频作者 趋势小小, 作者简介 ,相关视频:我是如何10万做到500万,几乎吃掉所有的利润,全靠牢记“二板定龙头 ...",
"url": "https://www.bilibili.com/video/BV1cQDYBsELd/"
}
],
"signal_3": [
{
"title": "精密基因药物开发公司:Beam Therapeutics(BEAM) - 美股之家",
"body": "Jan 28, 2020 ... com/beam.html 复制链接 复制链接. QQ群:249342519. 加群验证:美股之家. weinxin. 249342519. 微信号已复制. 微信公号:美港股百科全书. 微信搜: ...",
"url": "https://www.mg21.com/beam.html"
},
{
"title": "Beam Global宣布收购无人机技术公司ScoutDI",
"
... (truncated)
{
"xueqiu_cubes": null,
"xueqiu_meta": {
"http_status": 200,
"source": "http",
"login_required": true,
"hint": "set UZI_XQ_LOGIN=1 + run `python -m lib.xueqiu_browser login` (one-time)"
},
"tgb_mentions": [
{
"error": "tgb fetch failed: HTTPSConnectionPool(host='www.taoguba.com.cn', port=443): Max retries exceeded with url: /Article/list/all?keyword=BEAM (Caused by SSLError(SSLCertVerificationError(1, \"[SSL: CERTIFICATE_VERIFY_FAILED] certificate verify failed: Hostname mismatch, certificate is not valid for 'www.taoguba.com.cn'. (_ssl.c:992)\")))"
}
],
"ths_simu": [
{
"note": "ths simu endpoint requires login or blocked"
}
],
"dpswang": null,
"summary": {
"xueqiu_cubes_total": 0,
"high_return_cubes": 0,
"s_tier_holders": 0,
"a_tier_holders": 0,
"b_tier_holders": 0,
"tgb_mentions_count": 0,
"ths_evidence_count": 0,
"xueqiu_login_required": true,
"xueqiu_source": "http"
},
"fallback_queries": [
"淘股吧 实盘 BEAM 持仓",
"挑战者杯 BEAM",
"雪球 实盘组合 BEAM 50%",
"全国期货实盘大赛 BEAM"
],
"_note": "⚠️ XueQiu cubes 接口 2026 起需登录。当前未启用 Playwright 登录,0 cube 收录。如需启用:export UZI_XQ_LOGIN=1 然后 python -m lib.xueqiu_browser login 一次性登录。或 --skip-login-sources 接受跳过(其他维度不影响)。"
}